Issue 15

Are GLP-1 Drugs Becoming a Burden on National Healthcare?

Why not sign up for our future email newsletters? Sign up here.

Included in this issue:

LEAD STORY

Do GLP-1 Drugs Pose a Threat to National Healthcare Systems?

It’s almost impossible for us to compile an edition of The Pharma Navigator without a major update surrounding GLP-1 drugs. Although it is no secret that drugs are generating significant revenue for Big Pharma, is it doing so at the expense of our national healthcare systems? 

Read more here.

FEATURED STORIES

Agilent to Acquire BIOVECTRA and Expand Biopharma Solutions

Read more here.

Samsung Biologics' Record Quarter Driven by Biosimilars Sales

Read more here.

Alcami Expands Pharma Storage Capabilities in Garner

Read more here.

Drug Development Costs Set to Increase Amid BIOSECURE Act

Read more here.

Triastek and BioNTech Collaborate on 3D-Printed RNA Therapeutics

Read more here.

Roche Accelerates Obesity Treatment Development with Carmot Acquisition

Read more here.

Viking Therapeutics Advances Obesity Drug to Phase 3 with $300M Clinical Program

Read more here.

FDA Seeks Public Input on Biosimilar Development Guidance

Read more here.

BeiGene's New U.S. Hub Eyes Biologics Deals and Expansion

Read more here.